DEBORAH ANDERSON: Open Payments
NPI 1891801478 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 64 payments from 17 companies in 2025. Trend: 2023 $1,115 · 2024 $1,079 · 2025 $1,168
Food & beverage: $1,168
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $276 |
| Lilly USA, LLC | 11 | $196 |
| Dexcom, Inc. | 13 | $188 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $122 |
| ABBVIE INC. | 3 | $57 |
| BETA BIONICS, INC. | 2 | $48 |
| Insulet Corporation | 2 | $47 |
| Abbott Laboratories | 3 | $46 |
| Averitas Pharma Inc. | 1 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
Products named: Dexcom G6 Transmitter, MOUNJARO, JARDIANCE, Ozempic, Rybelsus, iLet Bionic Pancreas, Omnipod, FREESTYLE LIBRE 3.
Industry payments across PA — which companies pay providers there.
